{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:36:58Z","timestamp":1762101418974,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PEst-C\/SAU\/LA0001\/2011","PTDC\/SAU-OSM\/104124\/2008","SFRH\/BD\/61045\/2009","SFRH\/BD\/63962\/2009"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0001\/2011","PTDC\/SAU-OSM\/104124\/2008","SFRH\/BD\/61045\/2009","SFRH\/BD\/63962\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.transproceed.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,4,23]],"date-time":"2013-04-23T21:50:09Z","timestamp":1366753809000},"page":"1142-1148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Cyclosporine and Sirolimus on Insulin-Stimulated Glucose Transport and Glucose Tolerance in a Rat Model"],"prefix":"10.1016","volume":"45","author":[{"given":"P.","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sereno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mel\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2013.02.009_bib1","doi-asserted-by":"crossref","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis","volume":"4","author":"Heisel","year":"2004","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.transproceed.2013.02.009_bib2","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.transproceed.2013.02.009_bib3","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2125.2011.04118.x","article-title":"Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers","volume":"73","author":"\u00d8zbay","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.transproceed.2013.02.009_bib4","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2002.kid582.x","article-title":"Patient survival after renal transplantation: IV. Impact of post-transplant diabetes","volume":"62","author":"Cosio","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.transproceed.2013.02.009_bib5","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/j.1523-1755.2005.00349.x","article-title":"New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation","volume":"67","author":"Cosio","year":"2005","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.transproceed.2013.02.009_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00007890-200107150-00006","article-title":"Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation","volume":"72","author":"Sarwal","year":"2001","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.transproceed.2013.02.009_bib7","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0031-3955(03)00121-4","article-title":"Current immunosuppressive agents: efficacy, side effects, and utilization","volume":"50","author":"Smith","year":"2003","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.transproceed.2013.02.009_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1476-5381.2010.01018.x","article-title":"Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells","volume":"162","author":"\u00d8zbay","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.transproceed.2013.02.009_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14656566.6.3.479","article-title":"Sirolimus: a new option in transplantation","volume":"6","author":"Mota","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"19","key":"10.1016\/j.transproceed.2013.02.009_bib10","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1093\/hmg\/ddn192","article-title":"Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1","volume":"17","author":"Rosner","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.transproceed.2013.02.009_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbapap.2009.12.001","article-title":"Dissecting the role of mTOR: lessons from mTOR inhibitors","volume":"1804","author":"Dowling","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.transproceed.2013.02.009_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2012.01.024","article-title":"mTOR inhibition with rapamycin causes impaired insulin signalling and glucose uptake in human subcutaneous and omental adipocytes","volume":"355","author":"Pereira","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1016\/j.transproceed.2013.02.009_bib13","first-page":"473","article-title":"Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506","volume":"67","author":"Kay","year":"1989","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.transproceed.2013.02.009_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1742-7843.2007.00066.x","article-title":"Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase","volume":"100","author":"Gueguen","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1\u20132","key":"10.1016\/j.transproceed.2013.02.009_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0303-7207(99)00121-5","article-title":"TOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals","volume":"155","author":"Cutler","year":"1999","journal-title":"Mol Cell Endocrinol"},{"issue":"11","key":"10.1016\/j.transproceed.2013.02.009_bib16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ki.2010.268","article-title":"Sirolimus for calcineurin inhibitors in organ transplantation: contra","volume":"78","author":"Cravedi","year":"2010","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.transproceed.2013.02.009_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11892-009-0047-0","article-title":"Dyslipidemia following kidney transplantation: diagnosis and treatment","volume":"9","author":"Badiou","year":"2009","journal-title":"Curr Diab Rep"},{"issue":"4","key":"10.1016\/j.transproceed.2013.02.009_bib18","doi-asserted-by":"crossref","first-page":"E551","DOI":"10.1152\/ajpendo.00116.2005","article-title":"Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle","volume":"289","author":"Carvalho","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2013.02.009_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A model-based method for assessing insulin sensitivity from the oral glucose tolerance test","volume":"24","author":"Mari","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.transproceed.2013.02.009_bib20","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1172\/JCI111080","article-title":"In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus","volume":"72","author":"Kashiwagi","year":"1983","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.transproceed.2013.02.009_bib21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s001250050807","article-title":"Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation","volume":"40","author":"Yu","year":"1997","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.transproceed.2013.02.009_bib22","first-page":"1120","article-title":"Intestinal permeability after small intestinal transplantation and cyclosporine treatment","volume":"24","author":"Sigalet","year":"1992","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.transproceed.2013.02.009_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cbi.2010.02.029","article-title":"Long-term cyclosporine treatment in non- transplanted rats and metabolic risk factors of vascular diseases","volume":"185","author":"B\u00f6hmer","year":"2010","journal-title":"Chem Biol Interact"},{"issue":"6","key":"10.1016\/j.transproceed.2013.02.009_bib24","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/db09-1324","article-title":"Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue","volume":"59","author":"Houde","year":"2010","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.transproceed.2013.02.009_bib25","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1091\/mbc.12.12.4103","article-title":"The TOR signal transduction cascade controls cellular differentiation in response to nutrients","volume":"12","author":"Cutler","year":"2001","journal-title":"Mol Biol Cell"},{"issue":"3","key":"10.1016\/j.transproceed.2013.02.009_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1742-7843.2009.00427.x","article-title":"Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK\/HIJ mice","volume":"105","author":"Chang","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.transproceed.2013.02.009_bib27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.tp.0000229384.22217.15","article-title":"Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats","volume":"82","author":"Larsen","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.transproceed.2013.02.009_bib28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0022-3565(24)39134-7","article-title":"Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions","volume":"294","author":"Vaziri","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.transproceed.2013.02.009_bib29","first-page":"222","article-title":"The effect of cyclosporine and methylprednisolone on plasma lipoprotein levels in rats","volume":"125","author":"Espino","year":"1995","journal-title":"J Lab Clin Med"},{"issue":"2","key":"10.1016\/j.transproceed.2013.02.009_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mce.2012.10.030","article-title":"The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibits lipogenesis and alter expression of genes involved in lipid metabolism in human adipocytes","volume":"365","author":"Pereira","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1016\/j.transproceed.2013.02.009_bib31","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00007890-199810270-00013","article-title":"Immunosuppressive effects and safety of a sirolimus\/cyclosporine combination regimen for renal transplantation","volume":"66","author":"Kahan","year":"1998","journal-title":"Transplantation"},{"issue":"suppl B","key":"10.1016\/j.transproceed.2013.02.009_bib32","doi-asserted-by":"crossref","first-page":"B101","DOI":"10.1016\/S0149-2918(00)89027-X","article-title":"Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","volume":"22","author":"MacDonald","year":"2000","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.transproceed.2013.02.009_bib33","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/j.1476-5381.2011.01716.x","article-title":"Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats","volume":"165","author":"Deblon","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.transproceed.2013.02.009_bib34","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1172\/JCI119105","article-title":"Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells","volume":"98","author":"Redmon","year":"1996","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.transproceed.2013.02.009_bib35","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1210\/en.2003-1152","article-title":"Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling","volume":"145","author":"Uchizono","year":"2004","journal-title":"Endocrinology"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513001589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134513001589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:28:11Z","timestamp":1758576491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134513001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0041134513001589"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2013.02.009","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Cyclosporine and Sirolimus on Insulin-Stimulated Glucose Transport and Glucose Tolerance in a Rat Model","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2013.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}